474 related articles for article (PubMed ID: 26244716)
1. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
[TBL] [Abstract][Full Text] [Related]
2. Impact of immunosenescence on transplant outcome.
Heinbokel T; Hock K; Liu G; Edtinger K; Elkhal A; Tullius SG
Transpl Int; 2013 Mar; 26(3):242-53. PubMed ID: 23190423
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression of the elderly kidney transplant recipient.
Danovitch GM; Gill J; Bunnapradist S
Transplantation; 2007 Aug; 84(3):285-91. PubMed ID: 17700150
[TBL] [Abstract][Full Text] [Related]
4. Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly.
Gabardi S; Tullius SG; Krenzien F
Curr Opin Organ Transplant; 2015 Aug; 20(4):424-30. PubMed ID: 26126198
[TBL] [Abstract][Full Text] [Related]
5. Cancer and mTOR Inhibitors in Transplant Recipients.
de Fijter JW
Transplantation; 2017 Jan; 101(1):45-55. PubMed ID: 27547865
[TBL] [Abstract][Full Text] [Related]
6. Need for optimized immunosuppression in elderly kidney transplant recipients.
Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K
Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381
[TBL] [Abstract][Full Text] [Related]
7. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
8. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
9. The spectrum of complications of immunosuppression: is the time right for hand transplantation?
Brenner MJ; Tung TH; Jensen JN; Mackinnon SE
J Bone Joint Surg Am; 2002 Oct; 84(10):1861-70. PubMed ID: 12377920
[No Abstract] [Full Text] [Related]
10. The need for minimization strategies: current problems of immunosuppression.
Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
[TBL] [Abstract][Full Text] [Related]
11. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
Aiello FB; Furian L; Marino S; Marchini F; Cardillo M; De Fazio N; Rigotti P; Valente M
Int J Immunopathol Pharmacol; 2009; 22(4):1001-7. PubMed ID: 20074463
[TBL] [Abstract][Full Text] [Related]
12. New immunosuppressive strategies and the risk of infection.
Mueller NJ
Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
[TBL] [Abstract][Full Text] [Related]
13. Future trends in organ transplant recipients--important issues for dermatologists.
Zecher D; Steiger J
Curr Probl Dermatol; 2012; 43():71-80. PubMed ID: 22377921
[TBL] [Abstract][Full Text] [Related]
14. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
[TBL] [Abstract][Full Text] [Related]
15. [The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].
Schena FP; Maiorano A; Rossini M
G Ital Nefrol; 2008; 25 Suppl 44():S11-4. PubMed ID: 19048580
[TBL] [Abstract][Full Text] [Related]
16. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in the era of biological agents.
Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
[TBL] [Abstract][Full Text] [Related]
19. What's new in childhood organ transplantation.
Sudan D; Bacha EA; John E; Bartholomew A
Pediatr Rev; 2007 Dec; 28(12):439-53. PubMed ID: 18055642
[No Abstract] [Full Text] [Related]
20. Immunosenescence and organ transplantation.
Heinbokel T; Elkhal A; Liu G; Edtinger K; Tullius SG
Transplant Rev (Orlando); 2013 Jul; 27(3):65-75. PubMed ID: 23639337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
